Promab Biotechnologies
ProMab Biotechnologies, based in Albany, CA, has been at the forefront of medical innovation since 2001, specializing in CAR-T and CAR-NK cell development, mRNA-LNP development, and antibody engineering. With a commitment to advancing therapeutic applications, ProMab offers a comprehensive range of services that support everything from early discovery to clinical trials.
The company prides itself on its extensive in-house expertise, having generated over 5,000 monoclonal antibodies and completed 500 CAR-T projects, with multiple clinical trials underway. By leveraging cutting-edge technologies, ProMab aims to revolutionize cancer care and enhance vaccine development, making significant strides in the field of biotechnology.
Generated from the website
You might also like
Partial Data by Foursquare.